Development and Evaluation of Insulin Incorporated Nanoparticles for Oral Administration

<table class="table-group" id="tab5"><tr><td><table class="table"><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr class="thead"><td align="left">Time (days)</td><td align="center">Normal control<br/>Body weight (gms) ± SD</td><td align="center">Diabetic control<br/>Body weight (gms) ± SD</td><td align="center">Diabetic treated with insulin loaded<br/>Nanoparticle body weight (gms) ± SD</td></tr><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td align="left">01</td><td align="center">202.19 ± 16.23</td><td align="center">198.96 ± 20.39</td><td align="center">197.68 ± 13.45</td></tr><tr><td align="left">04</td><td align="center">205.58 ± 14.84</td><td align="center">168.99 ± 18.21</td><td align="center">191.47 ± 14.86</td></tr><tr><td align="left">07</td><td align="center">208.60 ± 14.07</td><td align="center">148.23 ± 18.40</td><td align="center">182.34 ± 16.64</td></tr><tr><td align="left">10</td><td align="center">213.40 ± 12.73</td><td align="center">137.51 ± 17.89</td><td align="center">177.57 ± 15.76</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Body weight change of normal, diabetic and insulin loaded nanoparticle treated rats over a period of 10 days.

International Scholarly Research Notices

tab5

Table 5

Table 5: Development and Evaluation of Insulin Incorporated Nanoparticles for Oral Administration 